AD Not Linked to Early CV Risk Markers

• by Kathryn Wighton

• May 27, 2026

Frailty may not limit semaglutide benefits

Patients with greater frailty showed larger improvements in health-related quality of life, while cardiovascular treatment effects did not differ significantly across frailty categories.

• by Andrea Surnit

• October 16, 2026

• 5 min

Tricuspid regurgitation thresholds reassessed

The proposed framework classified 30% of patients as high or extreme risk, compared with 12% classified as having severe or greater tricuspid regurgitation under established grading schemes.

• by Kathryn Wighton

• September 9, 2026

• 4 min

Three-Dimensional Transthoracic Echocardiography as a Tool for Patient Selection for Percutaneous Atrial Septal Defect Closure

• by Talya Finke, Uriel Katz, Tal Grupel, Yarden Sarouf Gat, Gur Mainzer, Sharon Borik Chiger

• September 12, 2026